GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a truly shift in how we approach type 2 diabetes . These new drugs help mimicking the body’s own GLP-1 substance , which promotes glucose https://livebookmarking.com/story21736642/glp-1-a-revolutionary-advance-in-diabetes-treatment